Literature DB >> 18182932

Treatment strategies in toxic epidermal necrolysis syndrome: where are we at?

Gerard J Abood1, Brian J Nickoloff, Richard L Gamelli.   

Abstract

Toxic epidermal necrolysis syndrome (TENS) is a rare, life-threatening medical emergency typically associated with recent drug exposure. Although several theories exist, recent insight has implicated the innate immune system as a significant contributor to the initiation and propagation of this devastating reaction. Standard therapies including transfer to specialized burn units, nutritional support, and protection from infection, remain the mainstay in the treatment of TENS. While alternative treatment strategies have been pursued and reported, there remains no published data that convincingly supports these further interventions. Given the rare nature of this syndrome, multi-institutional studies will be necessary and essential in improving the understanding and treatment of TENS.

Entities:  

Mesh:

Year:  2008        PMID: 18182932     DOI: 10.1097/BCR.0b013e31815f3658

Source DB:  PubMed          Journal:  J Burn Care Res        ISSN: 1559-047X            Impact factor:   1.845


  13 in total

1.  New insights in toxic epidermal necrolysis (Lyell's syndrome): clinical considerations, pathobiology and targeted treatments revisited.

Authors:  Philippe Paquet; Gérald E Piérard
Journal:  Drug Saf       Date:  2010-03-01       Impact factor: 5.606

2.  Toxic epidermal necrolysis from a cigarette burn.

Authors:  Joshua R Parker; Ross P Berkeley
Journal:  West J Emerg Med       Date:  2010-05

3.  Antiepileptic drugs toxicity: A case of toxic epidermal necrolysis in patient with phenytoin prophylaxis post-cranial radiation for brain metastases.

Authors:  Khalid AlQuliti; Basem Ratrout; Alaa AlZaki
Journal:  Saudi Pharm J       Date:  2014-02-25       Impact factor: 4.330

4.  Skin Detachment and Regrowth in Toxic Epidermal Necrolysis.

Authors:  Laurence Feldmeyer; Thomas Harr; Antonio Cozzio; Lars E French; Alexander A Navarini
Journal:  Case Rep Dermatol       Date:  2010-04-30

5.  Toxic epidermal necrolysis and concurrent granulomatosis with polyangiitis (Wegener's granulomatosis). Management of a rare case and review of the literature.

Authors:  Stratos S Sofos; J Ewing; L C Hughes; M I James
Journal:  Scars Burn Heal       Date:  2016-04-22

6.  Successful Treatment of Methampyrone-Induced Toxic Epidermal Necrolysis with Therapeutic Plasma Exchange.

Authors:  A Rumbiana; Z Wahab; S P Kurniawan; R M Naibaho; P Yogyartono
Journal:  Case Rep Med       Date:  2018-07-18

7.  Management of burn injuries--recent developments in resuscitation, infection control and outcomes research.

Authors:  David J Dries
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2009-03-11       Impact factor: 2.953

8.  Toxic epidermal necrolysis induced by lamotrigine treatment in a child.

Authors:  Youngsuk Yi; Jeong Ho Lee; Eun Sook Suh
Journal:  Korean J Pediatr       Date:  2014-03-31

9.  Biological skin substitutes to treat toxic epidermal necrolysis in a case with human immunodeficiency virus infection.

Authors:  Anokha Oomman; Richard Goodwin
Journal:  J Res Med Sci       Date:  2014-06       Impact factor: 1.852

10.  Association between HLA gene polymorphism and cutaneous adverse reactions caused by antiepileptic drugs.

Authors:  Jingang Zhang; Xinrui Li; Yuanyuan Su; Min Sun; Junbang Wang; Yunhua Hao
Journal:  Exp Ther Med       Date:  2018-01-25       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.